$UCLE US Nuclear Announces 3rd Quarter Financials and

New Post Public Reply Private Reply Replies (0) Message Board
louied91
176
$UCLE US Nuclear Announces 3rd Quarter Financials and Launch of New Marketing Initiatives


https://www.globenewswire.com/news-release/20...tives.html

LOS ANGELES, Dec. 04, 2024 (GLOBE NEWSWIRE) -- US Nuclear Corp. (OTC: UCLE) is pleased to announce that the 3rd quarter 2024 loss was reduced to $110,971 from $760,062 in 2023, a reduction of 89%. For the nine-month period, losses were reduced from $2,296,114 in 2023, to $728,320 in 2024, a reduction of $1,567,794, or 68%.

“These improvements in our path to profitability are just the beginning,” said Bob Goldstein, CEO of US Nuclear. “We’re working towards reducing our operating expenses 20%, while growing sales by 20% or greater!”

Revenues for the 3rd quarter were $610,864, an improvement of $17,362 over the 2023 revenues of $593,502. For the nine-month period, 2024 revenues were $1,741,182, an improvement of 9.6% over the 2023 nine-month revenues of $1,588,009.

Current Liabilities for the 3rd quarter 2024 were $2,412,805, a reduction of $2,426,690, or 50% from year-end 2023.

“We are setting aggressive sales targets for our sales professionals for the year ahead,” said Mr. Goldstein, “We are going to focus first on our nuclear monitoring product line, and we’re working on assembling packages that will include all monitoring devices necessary to protect a facility. We’ll market this line not only to current and future nuclear providers, but to fire, police, paramedics and government and regulatory agencies. Our contact and current customer list is quite extensive, and we expect an exciting year ahead for the Company!”

Please use the following link to see our 3rd quarter filing: US Nuclear

For sales and product information call Bob Goldstein at (818) 472-7071, or email Mark Kohn at mark.kohn@usnuclear.com. For Investor information call Jack Lennon at Chamberlain Capital (508) 360-8407 or at jjlennon@comcast.net

US Nuclear Corp (UCLE) Stock Research Links

UCLE Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Celebrating Cultural Excellence: Fukuoka Prize 2025 Laureates Revealed

Updated Category News Views 360

Fukuoka City Announces 2025 Fukuoka Prize Winners Fukuoka City has revealed the recipients of the prestigious Fukuoka Prize for 2025, honoring remarkable individuals in the field of Asian studies and the arts. This award is presented to those who excel in preserving and enhancing the rich tapestry of Asian culture. Fukuoka City is dedicated to celebrating these...

Continue Reading
Investors Unite: Join Flywire Corporation Legal Action Today

Updated Category News Views 168

Flywire Corporation Investors Take Action Against Securities Fraud In a moment of reckoning, investors in Flywire Corporation are seizing the opportunity to join a class action lawsuit concerning alleged securities fraud. The filing of this lawsuit has been initiated to hold accountable those responsible for misleading investors during a specified period, marking a...

Continue Reading
Venus Concept Secures $2.7 Million for Growth and Innovation

Updated Category News Views 323

Venus Concept Raises Significant Funds for Future Endeavors Venus Concept Inc. (NASDAQ: VERO), a renowned name in the global medical aesthetic technology arena, recently achieved a noteworthy milestone by closing a registered direct offering that provided around $1.57 million in gross proceeds. The offering consisted of 386,700 shares of common stock, sold at $4.06 each,...

Continue Reading
Revolutionary RAGE: UPENDS Launches Game-Changing Vape System

Updated Category News Views 211

UPENDS Unveils Groundbreaking Open Pod Vape System In a remarkable stride forward for the vaping industry, UPENDS has launched their revolutionary RAGE open pod system, designed to transform how enthusiasts experience vaping. As the European market continues to evolve, this cutting-edge device positions itself as a leader in user-centric innovation and compliance. The...

Continue Reading
Investors Target Kyverna Therapeutics: Key Details You Need

Updated Category News Views 101

Understanding Ongoing Investigations at Kyverna Therapeutics As the financial landscape continues to evolve, investors find themselves keenly interested in the developments surrounding Kyverna Therapeutics, Inc. (NASDAQ: KYTX). With a prominent law firm engaged in scrutinizing potential claims, the situation promises vital updates for concerned stakeholders. Faruqi &...

Continue Reading